​CANADA > France based Sanofi is set to invest €350 million($433.18 million) in Canadian vaccine facility

Sanofi logo For the construction of a new state of the art vaccine manufacturing facility, Sanofi is investing €350 million($433.18 million) at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario, Canada. Demonstrating Sanofi’s commitment to innovation and leadership in global public health, the investment bolsters Sanofi’s Canada operations. The new investment is the largest ever investment by Sanofi in a single building More …

USA > France based Sanofi is set to acquire Bioverativ Inc. for approximately $11.6 billion

Sanofi logo For $105 per share in cash, Sanofi is set to acquire all the outstanding shares of Bioverativ representing an equity value of approximately $11.6 billion. Both biopharmaceutical companies focus on therapies for hemophilia and other rare blood disorders and the transaction was unanimously approved by Board of Directors of both Sanofi and Bioverativ. According to Olivier Brandicourt, Sanofi’s Chief Executive More …